Exact Sciences (EXAS) Q4 Loss Narrows, Revenues Rise Y/Y
Exact Sciences(EXAS) Zacks Investment Research·2024-02-22 16:26Exact Sciences Corporation (EXAS) reported a net loss of 27 cents per share for fourth-quarter 2023, a significant improvement from the year-ago loss of 72 cents per share as well as the Zacks Consensus Estimate of a loss of 53 cents.Full-year net loss was $1.13 per share, narrower than the Zacks Consensus Estimate of a loss of $1.39. It also marked an improvement from a loss of $3.54 per share loss incurred in 2022.Revenues in DetailFourth-quarter consolidated revenues were $646.9 million, up 17% (up 18% o ...